Christopher Heery, CHIEF MEDICAL OFFICER at Arcellx, Inc. (ACLX), sold 35,238 shares at $82.20 ($2.9M) on 2025-09-30, disclosed to the SEC on 2025-09-30.
Scheduled sale ($2.9M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.55 | 5,300 | $427K | 14.9% |
| 2 | $81.46 | 14,204 | $1.2M | 40.4% |
| 3 | $81.46 | 14,204 | $1.2M | 40.4% |
| 4 | $82.20 | 1,530 | $126K | 4.4% |
| Total | $81.36 avg | 35,238 | $2.9M | 100% |
| Filing → |
| ACLX | SELL | 2026-01-12 | $393K | — | Filing → |
| ACLX | SELL | 2025-11-17 | $31K | — | Filing → |
| ACLX | SELL | 2025-09-29 | $6K | — | Filing → |